Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Cardano Faces Mounting Pressure as Whales Retreat and Technical Outlook Darkens

Dieter Jaworski by Dieter Jaworski
October 31, 2025
in Analysis, Blockchain, Ethereum & Altcoins, Trading & Momentum
0
Cardano Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

The Cardano network is experiencing significant selling pressure from major investors alongside concerning technical indicators, creating headwinds for the digital asset’s valuation. Despite ongoing ecosystem development, substantial outflows are driving prices downward.

Major Holders Trigger Sell-Off

A dramatic shift in sentiment among large ADA holders has emerged as a primary concern. Within a narrow 72-hour window, these so-called “whales” disposed of approximately 100 million ADA tokens. Wallets containing between 100 million and 1 billion ADA have been noticeably reducing their positions, signaling deteriorating confidence among the network’s most influential participants.

This institutional retreat extends to investment products. Cardano-focused funds registered outflows totaling $300,000 this week, marking a stark reversal from the previous week’s $3.7 million inflows. Over a three-week span, net outflows have accumulated to more than $25 million.

Technical Picture Points to Further Declines

Currently trading around $0.64, Cardano has declined over 15% this month. The asset briefly touched $0.611 during Thursday’s session, representing a 24-hour drop of 5.36%. Technical analysis reveals a concerning “death cross” formation on the hourly chart, where the 50-hour moving average crosses below the 200-hour average. This pattern typically indicates sustained selling momentum.

Should investors sell immediately? Or is it worth buying Cardano?

Market technicians identify the next significant support level at $0.59, while resistance awaits at $0.742 and $0.769. The Relative Strength Index sits at 40, reflecting weak buying interest. Although the MACD indicator shows a minor bullish crossover, sellers maintain control as long as ADA remains below key moving averages.

Development Progress Contrasts With Market Sentiment

Amid the bearish trading activity, Cardano’s development ecosystem continues advancing. The Cardano Foundation has initiated applications for the ‘.ada’ and ‘.cardano’ top-level domains, with implementation targeted for the first quarter of 2025. This initiative aims to strengthen the project’s brand identity.

Simultaneously, the Leios upgrade has progressed from research to engineering phases, promising enhanced network scalability. However, these developments have so far failed to counterbalance the institutional capital flight.

Broader Market Conditions Add Pressure

The wider cryptocurrency sector continues facing volatility, influenced by cautious commentary from the U.S. Federal Reserve and liquidations in leveraged futures positions. This environment compounds Cardano’s specific challenges, with market participants maintaining a defensive posture until clearer signals emerge.

Ad

Cardano Stock: Buy or Sell?! New Cardano Analysis from February 8 delivers the answer:

The latest Cardano figures speak for themselves: Urgent action needed for Cardano investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Cardano: Buy or sell? Read more here...

Tags: Cardano
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Next Post
Redcare Pharmacy Stock

Redcare Pharmacy Defies Market Pessimism with Robust Quarterly Performance

Omv Stock

Austrian Energy Giant OMV Defies Market Headwinds with Stellar Quarterly Performance

Voestalpine Stock

Voestalpine's Solar Strategy: A Green Pivot Amid Steel Sector Challenges

Recommended

UBS Stock

UBS Share Buyback Fails to Impress Amid Regulatory Fears

3 months ago
IBM Stock

IBM’s UFC Partnership Showcases AI Capabilities in Live Sports

3 months ago
ImmunityBio Stock

ImmunityBio Shares Gain Momentum on Strong Revenue and Regulatory Progress

6 days ago
BioNTech Stock

BioNTech’s Billion-Euro Forecast Shift Stuns Market

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Trending

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

by Jackson Burston
February 8, 2026
0

Investors in Rock Tech Lithium are in a holding pattern, with all eyes fixed on a pending...

Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com